The current GDM was managed using insulin, metformin, or lifestyle measures only in 47 (7.3%), 8 (1.2%), and 584 (91.0%), respectively; and data was missing in 3 (0.5%) participants. The gene discussed is INS; the disease is gestational diabetes.